Sulpiride solution
Based on 13 publication(s) in Google Scholar
Sulpiride solution is mainly composed of Sulpiride (HY-B1019). Sulpiride is an orally active dopamine D2/D3 receptor antagonist. Sulpiride is an atypical antipsychotic agent of the benzamide family. Sulpiride can be used in research into anxiety, depression and breast cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 15676-16-1
- Formel: C15H23N3O4S
- Molecular Weight:341.43
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Sulpiride solution
More- Nat Methods. 2024 Apr;21(4):680-691. [Abstract]
- Exp Mol Med. 2026 Aug;58(8):2762-2780.
- Neuron. 2023 May 17;111(10):1626-1636.e6. [Abstract]
- Adv Sci (Weinh). 2026 Jul;13(37):e19913. [Abstract]
- Mol Psychiatry. 2025 Dec 12. [Abstract]
- Acta Pharmacol Sin. 2024 Nov;45(11):2253-2266. [Abstract]
- J Headache Pain. 2026 Feb 9;27(1):39. [Abstract]
- J Headache Pain. 2022 Aug 10;23(1):98. [Abstract]
- Antioxidants (Basel). 2024 Jun 14;13(6):725. [Abstract]
- iScience. 2023 Mar 22;26(4):106488. [Abstract]
- J Neurosci. 2025 Sep 3;45(36):e0382252025. [Abstract]
- Brain Res. 2026 Mar 15:1875:150181. [Abstract]
- bioRxiv. 2023 Aug 25:2023.08.24.554559. [Abstract]
-
Bio/Physico-chemical Assay
-
Bio/Physico-chemical Assay
-
Bio/Physico-chemical Assay
-
In Vivo Efficacy Study
-
In Vivo Efficacy Study
Alle Dopamine Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Chemical Information
-
CAS. Nr. 15676-16-1
-
Molecular Weight 341.43
-
Formel C15H23N3O4S
-
SMILES
O=C(C1=CC(S(=O)(N)=O)=CC=C1OC)NCC2N(CCC2)CC
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (13)
-
Journal Impact Factor
-
Most Recent
-
Nat Methods
2024 Apr;21(4):680-691. PMID: 38036855
Sulpiride solution purchased from MedChemExpress. Usage Cited in: Nat Methods. 2024 Apr;21(4):680-691. [Abstract]
Normalized fluorescence change in gDA3m to indicated compounds (1 μM). Sulpiride (Sulp), D2R antagonist. n = 3 wells with 500-600 cells per well.
Sulpiride solution purchased from MedChemExpress. Usage Cited in: Nat Methods. 2024 Apr;21(4):680-691. [Abstract]
Activation of endogenous D2Rs by the D2-specific agonist quinpirole decreased the stimulus-evoked change in gDA3m fluorescence, reflecting presynaptic inhibition via D2 autoreceptors; this decrease was reversed by the addition of D2R antagonist Sulpiride (Sulp), and adding the D1R-specific antagonist SCH abolished the stimulation-evoked response.
-
-
Neuron
2023 May 17;111(10):1626-1636.e6. PMID: 36917979 -
Adv Sci (Weinh)
Nigra-Subthalamic Dopaminergic Circuitry Modulates and Represents Distinct Pain Modality in Physiological and Pain States in Mice. [Abstract]2026 Jul;13(37):e19913. PMID: 41944312 -
Mol Psychiatry
A co-culture model of dopaminergic and glutamatergic neurons derived from patients with idiopathic schizophrenia reveals a hypodopaminergic phenotype. [Abstract]2025 Dec 12. PMID: 41388144
Sulpiride solution purchased from MedChemExpress. Usage Cited in: Mol Psychiatry. 2025 Dec 12. [Abstract]
Peak frequency analysis of calcium traces retrieved from spontaneously active ALN and NGN2 neurons after 24 h treatment with DMSO (solvent control), 10 µM of Pramipexole dihydrochloride (DRD2 agonist) or 10 µM of Sulpiride (DRD2 antagonist).
-
Acta Pharmacol Sin
Single-dose methamphetamine administration impairs ORM retrieval in mice via excessive DA-mediated inhibition of PrLGlu activity. [Abstract]2024 Nov;45(11):2253-2266. PMID: 38914676
Sulpiride solution purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2024 Nov;45(11):2253-2266. [Abstract]
Experimental timeline and schematic of NOR test to examine the role of Sulpiride (D2R antagonist) on ORM retrieval in saline- and METH-treated mice. Saline or METH (2 mg/kg, i.p.) was injected 30 min before the test; simultaneously, saline or Sulpiride (0.25 μg/side) was microinfused bilaterally into PrL.
Sulpiride solution purchased from MedChemExpress. Usage Cited in: Acta Pharmacol Sin. 2024 Nov;45(11):2253-2266. [Abstract]
Bilateral infusion of Sulpiride (0.25 μg/side) effectively reversed the ORM retrieval impairment. In addition, the exploration time of novel object C compared with familiar object A was not significantly different in the Saline + Sulpiride (0.25 μg/side) group, while PI was decreased compared with the Saline + Saline group.
-
J Headache Pain
Downregulation of neuronal DRD2 drives microglia synaptic pruning and results in cognitive deficits by promoting CCL2 release in a rat model of chronic migraine. [Abstract]2026 Feb 9;27(1):39. PMID: 41663919 -
J Headache Pain
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine. [Abstract]2022 Aug 10;23(1):98. PMID: 35948867 -
Antioxidants (Basel)
Dopamine D2 Receptor Activation Blocks GluA2/ROS Positive Feedback Loop to Alienate Chronic-Migraine-Associated Pain Sensitization. [Abstract]2024 Jun 14;13(6):725. PMID: 38929165 -
iScience
Thrombospondin1 mimics rapidly relieve depression via Shank3 dependent uncoupling between dopamine D1 and D2 receptors. [Abstract]2023 Mar 22;26(4):106488. PMID: 37091229 -
J Neurosci
Potentiation of Nigra-Striatal Dopaminergic Projection Underpins Core Autism-Like Behaviors in Valproate-Exposed Mice. [Abstract]2025 Sep 3;45(36):e0382252025. PMID: 40769723 -
Brain Res
Single administration of vitamin C produces rapid antidepressant-like effects in female mice: A possible role of dopamine D2 receptor signalling. [Abstract]2026 Mar 15:1875:150181. PMID: 41577025 -
bioRxiv
2023 Aug 25:2023.08.24.554559. PMID: 37662187
Reinheit & Dokumentation
Verweise
[1]. Rüther, E et al. Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial. Pharmacopsychiatry vol. 32,4 (1999): 127-35. [Content Brief]
[2]. Jaworski, J N et al. Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine. European journal of pharmacology vol. 418,3 (2001): 201-6. [Content Brief]
[3]. Zarrindast, Mohammad-Reza et al. Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis. Neurobiology of learning and memory vol. 186 (2021): 107538. [Content Brief]
[4]. Li, Jian et al. Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer. Acta pharmacologica Sinica vol. 38,9 (2017): 1282-1296. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)